Current status of liquid biopsies for the detection and management of prostate cancer

In recent years, new therapeutic options have become available for prostate cancer (PC) patients, generating an urgent need for better biomarkers to guide the choice of therapy and monitor treatment response. Liquid biopsies, including circulating tumor cells (CTCs), circulating nucleic acids, and e...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yi-Tsung, Delijani, Kevin, Mecum, Andrew, Goldkorn, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559244/
https://www.ncbi.nlm.nih.gov/pubmed/31239778
http://dx.doi.org/10.2147/CMAR.S170380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559244/
https://www.ncbi.nlm.nih.gov/pubmed/31239778
http://dx.doi.org/10.2147/CMAR.S170380

Ejemplares similares